P Jirholt1, M Ohlin, C A Borrebaeck
1Department of Immunotechnology, Lund University, Lund, Sweden.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
This study introduces a new molecular design method by shuffling in vivo formed complementarity determining regions (CDR) into antibody framework regions. This approach generates diverse synthetic antibody gene libraries for novel therapeutic development.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: